Could an intellectual property waiver boost Africa's vaccine rollout?

Trade & Manufacturing

Elly Darkin, Associate in the Trade & Manufacturing Practice, and Isabelle Trick, Senior Associate in the Global Macro Practice, discuss vaccine rollout in Africa and whether a temporary intellectual property waiver for vaccines will help or hinder efforts to vaccinate Africa and the wider developing world.

They focus on the challenges facing vaccination efforts in Africa and some of the potential routes forward, particulary exploring a proposal that has been presented at the WTO that seeks to waiver IP rights for vaccines and other covid-related medicines. They explain what the current rules are, what the proposal seeks to changes, and examines the practical implications this will have on the real constraints on companies and governments at the moment.

You can subscribe to the Global Counsel Podcast on Apple and Spotify, where you can also leave us a rating and a review. We release new episodes every Thursday.

You can read Isabelle's blog on the vaccine rollout in Africa here


The views expressed in this note can be attributed to the named author(s) only.